HoustonMC. The role of vascular biology, nutrition and nutraceuticals in the prevention and treatment of hypertension. J Am Nutraceut Assoc, 2002; 1:5–70.
2.
LinJJ, ChangHC, KuCT, ChenHY. Hydrochlorothiazide hypertension treatment induced metabolic effects in type 2 diabetes: A meta-analysis of parallel-design RCTs. Eur Rev Med Pharmacol Sci, 2016; 20:2926–2934.
3.
ScheenAJ. Type 2 diabetes and thiazide diuretics. Curr Diab Rep 2018, 5; 18:6.
4.
RoushGC, AbdelfattahR, SongS, et al.Hydrochlorothiazide and alternative diuretics versus renin-angiotensin system inhibitors for the regression of left ventricular hypertrophy: A head-to-head meta-analysis. J Hypertens, 2018; 36:1247–1255.
ZisapelN.New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br J Pharmacol, 2018 Jan 10 [Epub ahead of print]; DOI: 10.1111/bph.14116.
7.
Sanches Machado d' AlmeidaK, Ronchi SpillereS, ZuchinaliP, Corrêa SouzaG. Mediterranean diet and other dietary patterns in primary prevention of heart failure and changes in cardiac function markers: A systematic review. Nutrients, 2018; 10:pii:E58.
CliffordT, AllertonDM, BrownMA, et al.Minimal muscle damage after a marathon and no influence of beetroot juice on inflammation and recovery. Appl Physiol Nutr Metab, 2017; 42:263–270.
10.
HoustonM, MinichD, SinatraST, et al.Recent science and clinical application of nutrition to coronary heart disease. J Am Coll Nutr, 2018; 37:169–187.
11.
LiXS, ObeidS, KlingenbergR, et al.Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: A prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur Heart J, 2017; 38:814–824.
12.
LockyerS, CoronaG, YaqoobP, et al.Secoiridoids delivered as olive leaf extract induce acute improvements in human vascular function and reduction of an inflammatory cytokine: A randomised, double-blind, placebo-controlled, cross-over trial. Br J Nutr, 2015; 114:75–83.
13.
SusalitE, AgusN, EffendiI, et al.Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: Comparison with Captopril. Phytomedicine, 2011; 18:251–258.
14.
FemlakM, Gluba-BrzózkaA, Ciałkowska-RyszA, RyszJ. The role and function of HDL in patients with diabetes mellitus and the related cardiovascular risk. Lipids Health Dis, 2017; 16:20–7.
15.
SrivastavaRAK. Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease. Mol Cell Biochem, 2018; 440:167–187.
16.
von EckardsteinA, RohrerL. HDLs in crises. Curr Opin Lipidol, 2016; 27:264–273.
17.
SalazarJ, OlivarLC, RamosE, et al.Dysfunctional high-density lipoprotein: An innovative target for proteomics and lipidomics. Cholesterol, 2015; 2015:29641–7.
18.
BertholdHK, NainiA, Di MauroS, et al.Effect of ezetimibe and/or simvastatin on coenzyme Q10 levels in plasma: A randomised trial. Drug Saf, 2006; 29:703–712.
19.
SahebkarA, Simental-MendíaLE, FerrettiG, et al.Statin therapy and plasma vitamin E concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials. Atherosclerosis, 2015; 243:579–588.
20.
YokoyamaM, OrigasaH, MatsuzakiM, et al.Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): A randomised open-label, blinded endpoint analysis. Lancet, 2007; 369:1090–1098.
21.
BardhanJ, ChakrabortyR, RaychaudhuriU. The 21st century form of vitamin E—tocotrienol. Curr Pharm Des, 2011; 17:2196–2205.
22.
StoneNJ, RobinsonJG, LichtensteinAH, et al.2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2014; 63:2889–2934.
